Deals & Corporate Governance
- 
									June 17, 2025
									Oregon's Corporate Ownership Law Puts PE At CrossroadsA new law in Oregon is leaving private equity firms and other organizations at a crossroads as they try to figure out how to navigate stricter rules focused on corporate ownership of healthcare practices. 
- 
									June 17, 2025
									Surgery Partners Rejects $3.3B Bain Offer, Eyes Public GrowthSurgery Partners, a short-stay surgical facility owner, said on Tuesday it has ended talks with Bain Capital regarding a nearly $3.3 billion take-private proposal, saying it sees a stronger future as a public company. 
- 
									June 17, 2025
									Kirkland-Led Lilly Inks $1.3B Deal For Cardio Drug Co. VerveKirkland-advised Eli Lilly and Co. said Tuesday it will acquire Paul Weiss-advised Verve Therapeutics in a deal worth up to $1.3 billion, continuing its push into next-generation genetic medicines for heart disease. 
- 
									June 13, 2025
									AbbVie Sues Colo. Over State Discount Drug LawAbbVie Inc. on Thursday filed suit in Colorado federal court seeking to block an incoming state law it alleges conflicts with the federal 340B drug discount program by forcing pharmaceutical manufacturers to sell drugs at steep discounts to commercial pharmacy chains like Walgreens and CVS. 
- 
									June 13, 2025
									Health Tech Co. Overstated AI Capabilities, Investor Suit SaysHealth technology company Tempus AI Inc. and two of its executives face a shareholder class action over claims the company misrepresented its artificial intelligence capabilities, the value of its contracts and the credibility of certain joint ventures, among other things. 
- 
									June 13, 2025
									Ga. Medical Co. Accused Of Infringing Swedish Co.'s PatentsA Swedish medical device company has sued Georgia-based MedWay Group Inc. in federal court for allegedly infringing its patents for foam dressings used in wound care and management. 
- 
									June 12, 2025
									5 Firms Guide $1.25B BioNTech, CureVac Oncology DealGerman biotech firm BioNTech SE said Thursday that it will acquire CureVac NV, a clinical-stage mRNA specialist, in an all-stock oncology-focused deal valuing it at about $1.25 billion and involving five legal advisers. 
- 
									June 11, 2025
									PepGen Faces Investor Suit Over Muscular Dystrophy DrugClinical-stage biotech company PepGen Inc. has been hit with a proposed shareholder class action alleging it misled investors about the efficacy and commercial prospects of its muscular dystrophy drug, causing share price declines as investors learned of the drug's clinical trials' shortcomings. 
- 
									June 10, 2025
									Healthcare Deals This Week: Omada, Antares, AmplifyThe healthcare industry saw a few notable deals this past week, including a much-anticipated IPO from digital health company Omada and a handful of private fundraises among startups. 
- 
									June 10, 2025
									Ill. Judge Questions Standing In Biogen Antitrust SuitAn Illinois federal judge seemed skeptical Tuesday that health benefit plans accusing Biogen of impairing competition for its multiple sclerosis drug, Tecfidera, have standing to bring their lawsuit under decades-old precedent allowing only direct purchasers to recoup damages. 
- 
									June 10, 2025
									23andMe Auction Is A Wake-Up Call For Data Privacy LawWith its giant trove of customer genetic and health data up for auction, direct-to-consumer genetic testing company 23andMe's bankruptcy is revealing glaring gaps in federal data privacy laws. 
- 
									June 10, 2025
									Drug Cos. Face Persistent Scrutiny Over Physician KickbacksDrugmakers continue to become ensnared in — and settle — investigations into illegal payments to healthcare providers for participating in sham speaker programs. These payments raise ethical questions about patient harm and whether they are seen as a cost of doing business. 
- 
									June 09, 2025
									AI-Powered Cancer Diagnostics Firm Targets $400M IPOCaris Life Sciences Inc., a developer of artificial-intelligence enhanced cancer diagnostic tests, on Monday launched plans for an estimated $400 million initial public offering, represented by Latham & Watkins LLP and underwriters counsel Cooley LLP. 
- 
									June 09, 2025
									Rite Aid Gets Stay Of Appeals From Its Earlier BankruptcyThe New Jersey bankruptcy judge overseeing Rite Aid's current insolvency case pressed pause Monday on appeals of orders he entered last year in the drugstore chain's previous Chapter 11. 
- 
									June 06, 2025
									Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M DemandMasimo Corp. fought back against founder Joe Kiani's motion to dismiss the company's Delaware Chancery Court suit seeking a declaration that he's not due a $450 million payout after his ouster as CEO, arguing that bid is an "improper attempt to evade" the Delaware court's jurisdiction. 
- 
									June 06, 2025
									Taxation With Representation: Winston, Stibbe, Weil, GoodwinIn this week's Taxation With Representation, Chart Industries Inc. and Flowserve Corp. merge, Aedifica NV and Cofinimmo NV unite, Sanofi buys Blueprint Medicines Corp., and Kimberly-Clark Corp. sells a majority stake in its international tissue business to Suzano. 
- 
									June 05, 2025
									Latham-Led Virtual Health Startup Omada Prices $150M IPOVenture-backed virtual care provider Omada Health Inc. on Thursday priced a $150 million initial public offering within its marketed range, represented by Latham & Watkins LLP and underwriters counsel Davis Polk & Wardwell LLP. 
- 
									June 05, 2025
									Elon Musk Seeks $5B For AI Startup, Amid Other ReportsElon Musk is planning a $5 billion debt sale for his AI startup, Ontario’s pension seeks final bids for an Indian hospital system, and Merck eyes a Swiss biotech with a potential $3 billion price tag. Here's a rundown of these and other notable deal rumors from the last week. 
- 
									June 05, 2025
									$1.36B Home Healthcare Deal Dropped Amid FTC ScrutinyHealthcare solutions company Owens & Minor said Thursday that it's abandoning its $1.36 billion plan to buy home-based care business Rotech Healthcare Holdings after the Federal Trade Commission's scrutiny proved too much to bear. 
- 
									June 04, 2025
									States Take Aim At Healthcare REITsState lawmakers seeking to curb healthcare investment models they see as harmful to patients have sharpened their focus on real estate investment trusts, putting forth bills to restrict their ownership of healthcare real estate or increase oversight of such transactions. 
- 
									June 03, 2025
									InnovAge To Pay $27M To Resolve IPO Investors' SuitInnovAge Holding Corp. and a class of stockholders have agreed to a $27 million settlement to resolve claims that the senior-health care company made misleading statements in an initial public offering that later caused stock prices to tank after a government audit exposed the falsehoods. 
- 
									June 03, 2025
									Latham Advises Atai In $390M Merger With Beckley PsytechU.S.-German biopharmaceutical company atai Life Sciences, advised by Latham & Watkins LLP, said in an announcement Monday that it will acquire Beckley Psytech, led by Mayer Brown LLP and CMS Cameron McKenna Nabarro Olswang LLP, in an all-share transaction that values Beckley at approximately $390 million, creating a combined company focused on fast-acting mental health therapies. 
- 
									June 03, 2025
									Stibbe, A&O Shearman Guide $13.8B Healthcare REIT MergerBelgian real estate investment trusts Aedifica NV and Cofinimmo NV said Tuesday they have agreed to merge, forming what they said will be Europe's largest healthcare real estate investment trust, with a combined gross asset value of approximately €12.1 billion ($13.8 billion). 
- 
									June 03, 2025
									Georgia Health System Selects Legal Chief As CEOThe Southeast Georgia Health System Inc. has installed its interim president and chief executive officer — who was most recently its chief legal officer — as president and CEO. 
- 
									June 03, 2025
									Simpson Thacher Adds Ex-Weil M&A Pro In NYCSimpson Thacher & Bartlett LLP announced Monday the hiring of a former counsel at Weil Gotshal & Manges LLP as a partner in its mergers and acquisitions practice in New York. 
Expert Analysis
- 
								
								ESG Around The World: Mexico  ESG has yet to become part of the DNA of the Mexican business model, but huge strides are being made in that direction, as more stakeholders demand that companies adopt, at the least, a modicum of sustainability commitments and demonstrate how they will meet them, says Carlos Escoto at Galicia Abogados. 
- 
								
								The Case For Post-Bar Clerk Training Programs At Law Firms  In today's competitive legal hiring market, an intentionally designed training program for law school graduates awaiting bar admission can be an effective way of creating a pipeline of qualified candidates, says Brent Daub at Gilson Daub. 
- 
								
								10 Takeaways From New HHS Federal Compliance Guidelines  The U.S. Department of Health and Human Services' recently issued general compliance program guidance is the first of its kind that would apply across all health care stakeholders, and signals the agency’s first step to improve and update existing compliance guidance, says Melissa Wong at Holland & Knight. 
- 
								
								Attorneys Have An Ethical Duty To Protect The Judiciary  The tenor of public disagreement and debate has become increasingly hostile against judges, and though the legislative branch is trying to ameliorate this safety gap, lawyers have a moral imperative and professional requirement to stand with judges in defusing attacks against them and their rulings, says Deborah Winokur at Cozen O'Connor. 
- 
								
								Cross-Market Implications In FTC's Anesthesia Complaint  The Federal Trade Commission's recent complaint against a private equity firm's acquisition of anesthesiology practices highlights the controversial issue of cross-market harm in health care provider mergers, and could provide important insights into how a court may view such theories of harm, say Christopher Lau and Dina Older Aguilar at Cornerstone Research. 
- 
								
								AI Can Help Lawyers Overcome The Programming Barrier  Legal professionals without programming expertise can use generative artificial intelligence to harness the power of automation and other technology solutions to streamline their work, without the steep learning curve traditionally associated with coding, says George Zalepa at Greenberg Traurig. 
- 
								
								Cos. Must Adapt To Calif. Immigration Data Privacy Law  California’s recently signed A.B. 947 expands the California Consumer Privacy Act and brings the state in line with other comprehensive privacy laws that address immigration status, meaning companies should make any necessary updates to their processes and disclosures, say Kate Lucente and Matt Dhaiti at DLA Piper. 
- 
								
								Looking For Defense Contract Appeal Trends In Annual Report  A deep dive into the Armed Services Board of Contract Appeals annual report for the 2023 fiscal year reveals increases in the number of cases filed, pending motions and expedited or accelerated cases, while the board disposed of fewer cases than in prior fiscal years, say Scott Flesch and Alexandra Prime at Miller & Chevalier. 
- 
								
								Preparing Law Students For A New, AI-Assisted Legal World  As artificial intelligence rapidly transforms the legal landscape, law schools must integrate technology and curricula that address AI’s innate challenges — from ethics to data security — to help students stay ahead of the curve, say Daniel Garrie at Law & Forensics, Ryan Abbott at JAMS and Karen Silverman at Cantellus Group. 
- 
								
								ESG Around The World: South Korea  Numerous ESG trends have materialized in South Korea in the past three years, with impacts ranging from greenwashing prevention and carbon neutrality measures to workplace harassment and board diversity initiatives, say Chang Wook Min and Hyun Chan Jung at Jipyong. 
- 
								
								General Counsel Need Data Literacy To Keep Up With AI  With the rise of accessible and powerful generative artificial intelligence solutions, it is imperative for general counsel to understand the use and application of data for myriad important activities, from evaluating the e-discovery process to monitoring compliance analytics and more, says Colin Levy at Malbek. 
- 
								
								A Look At Successful Bid Protests In FY 2023  Attorneys at Sheppard Mullin look beyond the statistics in the U.S. Government Accountability Office’s recent annual report on bid protests, sharing their insights about nine categories of sustained protests, gained from reading every fiscal year 2023 decision in which the protester had a positive result. 
- 
								
								Rite Aid's Reasons For Ch. 11 Go Beyond Opioid Suits.jpg)  Despite opioid-related lawsuits being the perceived reason that pushed Rite Aid into bankruptcy, the company's recent Chapter 11 filing reveals its tenuous position in the pharmaceutical retail market, and only time will tell whether bankruptcy will right-size the company, says Daniel Gielchinsky at DGIM Law.